QuartzBio secures growth investment from Eir Partners to advance AI‑driven clinical trial intelligence, improving efficiency, data integrity, and outcomes for biopharma. New capital fuels product enhancements as leading biopharma adopt...
Read More
QuartzBio is the only company purpose-built to deliver end-to-end Sample and Biomarker Intelligence for clinical-stage biopharma teams. Powered by a network of domain-specific AI agents, our solutions transform fragmented data into actionable intelligence, enabling conversational insights into your unified ecosystem of sample, clinical, and biomarker data.
QUARTZBIO® is a registered trademark of Precision Regulatory and Translational Sciences, Inc., dba QuartzBio, in the United States and/or other jurisdictions. All rights reserved.
© 2026 QuartzBio.
All rights reserved.
Privacy Policy | GDPR
